EUVIMEDEUVIMED entdecken
Crossref

P-242: Results of the first molecular study of monogenic obesity at Elizalde’s children hospital in Buenos Aires city, Argentina

E A San Martin, J Serra, M Franciulli, M E Andres, M Silberkasten, L Braguinsky, N Grimberg, V M Jimenez, A Franchello, V Britto

Hormone Research in Paediatrics · 04.11.2026 · 99 (Supplement_4)

DOI: 10.1159/hrp/adaag020.300 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hormone Research in Paediatrics, online erschienen am 04.11.2026. Verfasst von E A San Martin und 9 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Monogenic syndromic and non-syndromic obesity are a rare form of severe early-onset obesity. They are associated with dysfunction in the leptin-melanocortin pathway in the hypothalamus, which is responsible for regulating energy balance. Non-syndromic monogenic obesity can be a challenge to diagnose from other causes of severe obesity without genetic testing. Currently, specific treatments exist for some of these conditions Objectives Report the results of a genetic diagnosis program with a genetic panel for obesity in children with early onset severe obesity and hyperphagia in Pedro de Elizalde’s Children Hospital in Argentina Methods Retrospective, descriptive, cross-sectional study from clinical records review. Inclusion criteria: children with BMI SD >3 and early onset obesity plus hyperphagia were screened between June 2021 and November 2025 by a next-generation sequencing based, targeted DNA custom panel for 79 known-obesity-related genes and 16p11.2 chromosomal region. Ethical considerations: the study was approved by Elizalde’s Children Hospital ethics committee Results A total of 164 patients were included. Mean age 8.9 ± 4.9 years (range 0.5-19 years), Mean BMI 32.8 ± 8.8 (range 11.7–68.2), Mean BMI-Z score: 4.78. In 30 patients did not have detected variants (18.29 %), 134 patients did have detected variants (81.70 %). 212 variants were detected: 191 were uncertain variants and 21 pathogenic or likely pathogenic. Gen and genomic coordinates that showed pathogenic or likely pathogenic variants were: arr[GRCh37], CEP290, BBS2, ARL6, MECP2, GNAS, MC4R, BBS4, IFT172, KIDINS220, ALMS, BBS9 and arr[hg19]. Among the 191 uncertain variants detected, the most frequent variants were: PCNT, ALMS1, NRP2, CEP290 and PLXNA3.

Conclusions

81.70% of the panels showed genetic variants. 10 variants were pathogenic and 11 likely pathogenic. This study is part of a broader project to better define the prevalence of these genetic variants and find genotype/phenotype correlations.

Zitieren

APA

Martin, E. A. S., Serra, J., Franciulli, M., Andres, M. E., Silberkasten, M., Braguinsky, L., Grimberg, N., Jimenez, V. M., Franchello, A., & Britto, V. (2026). P-242: Results of the first molecular study of monogenic obesity at Elizalde’s children hospital in Buenos Aires city, Argentina. Hormone Research in Paediatrics, 99(Supplement_4). https://doi.org/10.1159/hrp/adaag020.300

Vancouver

Martin EAS, Serra J, Franciulli M, Andres ME, Silberkasten M, Braguinsky L, et al. P-242: Results of the first molecular study of monogenic obesity at Elizalde’s children hospital in Buenos Aires city, Argentina. Hormone Research in Paediatrics. 2026;99(Supplement_4). doi:10.1159/hrp/adaag020.300

BibTeX
@article{Martin2026,
  author = {Martin, E A San and Serra, J and Franciulli, M and Andres, M E and Silberkasten, M and Braguinsky, L and Grimberg, N and Jimenez, V M and Franchello, A and Britto, V},
  title = {P-242: Results of the first molecular study of monogenic obesity at Elizalde’s children hospital in Buenos Aires city, Argentina},
  journal = {Hormone Research in Paediatrics},
  year = {2026},
  volume = {99},
  number = {Supplement_4},
  doi = {10.1159/hrp/adaag020.300}
}
Kostenlos starten →